| LncRNAs | Disease | Experimental methods | Regulated | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Pubmed ID | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LINC01224 | hepatocellular carcinoma | qRT-PCR, Western Blot Analysis, Dual-Luciferase Reporter Assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31902747 | 2020 |
| LINC01224 | Non-Small Lung Cancer | Dual-luciferase reporter assay;RNA pull-down assay; | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 34403779 | 2021 |
| LINC01224 | Endometrial Carcinoma | Flow cytometry assay;RNA pull-down assay;Western blot;Flow Cytometry assay;RNA pull-down; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 34278482 | 2021 |